116 related articles for article (PubMed ID: 9468546)
1. Protein kinase C-alpha: a novel target for the therapy of androgen-independent prostate cancer? (Review-hypothesis).
O'Brian CA
Oncol Rep; 1998; 5(2):305-9. PubMed ID: 9468546
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol antagonizes EGFR-dependent Erk1/2 activation in human androgen-independent prostate cancer cells with associated isozyme-selective PKC alpha inhibition.
Stewart JR; O'Brian CA
Invest New Drugs; 2004 Apr; 22(2):107-17. PubMed ID: 14739659
[TBL] [Abstract][Full Text] [Related]
3. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells.
Powell CT; Brittis NJ; Stec D; Hug H; Heston WD; Fair WR
Cell Growth Differ; 1996 Apr; 7(4):419-28. PubMed ID: 9052983
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of protein kinase C-induced apoptosis in prostate cancer cells.
Gonzalez-Guerrico AM; Meshki J; Xiao L; Benavides F; Conti CJ; Kazanietz MG
J Biochem Mol Biol; 2005 Nov; 38(6):639-45. PubMed ID: 16336777
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 inhibits membrane association of protein kinase C alpha in a human prostate cancer cell line, PC3.
Lamm ML; Long DD; Goodwin SM; Lee C
Endocrinology; 1997 Nov; 138(11):4657-64. PubMed ID: 9348191
[TBL] [Abstract][Full Text] [Related]
6. Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha.
Garcia-Bermejo ML; Leskow FC; Fujii T; Wang Q; Blumberg PM; Ohba M; Kuroki T; Han KC; Lee J; Marquez VE; Kazanietz MG
J Biol Chem; 2002 Jan; 277(1):645-55. PubMed ID: 11584014
[TBL] [Abstract][Full Text] [Related]
7. Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta.
Fujii T; García-Bermejo ML; Bernabó JL; Caamaño J; Ohba M; Kuroki T; Li L; Yuspa SH; Kazanietz MG
J Biol Chem; 2000 Mar; 275(11):7574-82. PubMed ID: 10713064
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C mediated anti-proliferative glucocorticoid-sphinganine synergism in cultured Pollard III prostate tumor cells.
Sosnowski J; Stetter-Neel C; Cole D; Durham JP; Mawhinney MG
J Urol; 1997 Jul; 158(1):269-74. PubMed ID: 9186373
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary artery smooth muscle cells from chronically hypoxic neonatal calves retain fetal-like and acquire new growth properties.
Xu Y; Stenmark KR; Das M; Walchak SJ; Ruff LJ; Dempsey EC
Am J Physiol; 1997 Jul; 273(1 Pt 1):L234-45. PubMed ID: 9252561
[TBL] [Abstract][Full Text] [Related]
10. Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells.
Pickett CA; Manning N; Akita Y; Gutierrez-Hartmann A
Mol Endocrinol; 2002 Dec; 16(12):2840-52. PubMed ID: 12456804
[TBL] [Abstract][Full Text] [Related]
11. Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells.
Win HY; Acevedo-Duncan M
Cell Prolif; 2009 Apr; 42(2):182-94. PubMed ID: 19243387
[TBL] [Abstract][Full Text] [Related]
12. Ribozyme-mediated inhibition of PKCalpha sensitizes androgen-independent human prostate cancer cells to cisplatin-induced apoptosis.
Orlandi L; Binda M; Folini M; Bearzatto A; Villa R; Daidone MG; Zaffaroni N
Prostate; 2003 Feb; 54(2):133-43. PubMed ID: 12497586
[TBL] [Abstract][Full Text] [Related]
13. 12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha.
Liu B; Maher RJ; De Jonckheere JP; Popat RU; Stojakovic S; Hannun YA; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 400B():707-18. PubMed ID: 9547622
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms.
Gavrielides MV; Frijhoff AF; Conti CJ; Kazanietz MG
Curr Drug Targets; 2004 Jul; 5(5):431-43. PubMed ID: 15216909
[TBL] [Abstract][Full Text] [Related]
15. Atypical protein kinase C phosphorylates IKKalphabeta in transformed non-malignant and malignant prostate cell survival.
Win HY; Acevedo-Duncan M
Cancer Lett; 2008 Nov; 270(2):302-11. PubMed ID: 18571841
[TBL] [Abstract][Full Text] [Related]
16. Involvement of multiple protein kinase C isozymes in the ACTH secretory pathway of AtT-20 cells.
McFerran BW; MacEwan DJ; Guild SB
Br J Pharmacol; 1995 May; 115(2):307-15. PubMed ID: 7670732
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.
Miyake H; Nelson C; Rennie PS; Gleave ME
Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316
[TBL] [Abstract][Full Text] [Related]
18. The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells.
Henttu P; Vihko P
Biochem Biophys Res Commun; 1998 Mar; 244(1):167-71. PubMed ID: 9514905
[TBL] [Abstract][Full Text] [Related]
19. c-fos promoter insensitivity to phorbol ester and possible role of protein kinase C in androgen-independent cancer cells.
Krongrad A; Bai G
Cancer Res; 1994 Dec; 54(23):6073-7. PubMed ID: 7954449
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid-induced transition from protein kinase C beta to protein kinase C alpha in differentiated F9 cells: correlation with altered regulation of proto-oncogene expression by phorbol esters.
Khuri FR; Cho Y; Talmage DA
Cell Growth Differ; 1996 May; 7(5):595-602. PubMed ID: 8732669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
